Middle East Pharmaceutical Industries Co. (4016.SR)
SAR 131.6
(0.3%)
SAR 131.6
(0.3%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 207.04 Million SAR | 16.53% |
| 2022 | 177.67 Million SAR | 4.99% |
| 2021 | 169.22 Million SAR | -1.48% |
| 2020 | 171.77 Million SAR | 20.17% |
| 2019 | 142.93 Million SAR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 64.34 Million SAR | 38.49% |
| 2024 Q1 | 46.46 Million SAR | -23.21% |
| 2023 Q4 | 60.5 Million SAR | 0.0% |
| 2023 Q3 | 60.5 Million SAR | 19.25% |
| 2023 FY | 199.65 Million SAR | 12.37% |
| 2023 Q2 | 50.73 Million SAR | 51.96% |
| 2023 Q1 | 33.38 Million SAR | -37.0% |
| 2022 Q1 | 38.73 Million SAR | 0.0% |
| 2022 FY | 177.67 Million SAR | 4.99% |
| 2022 Q4 | 52.99 Million SAR | 0.0% |
| 2022 Q2 | 47.11 Million SAR | 21.64% |
| 2022 Q3 | 52.99 Million SAR | 12.48% |
| 2021 FY | 169.22 Million SAR | -1.48% |
| 2020 FY | 171.77 Million SAR | 20.17% |
| 2019 FY | 142.93 Million SAR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Al-Dawaa Medical Services Company | 2.06 Billion SAR | 89.972% |
| Nahdi Medical Company | 3.52 Billion SAR | 94.122% |
| Al-Razi Medical Co. | 14.07 Million SAR | -1371.135% |
| Almujtama Alraida Medical Co. | 129.2 Million SAR | -60.244% |